Paeonol Inhibits IL-1 β-Induced Inflammation via PI3K/Akt/NF-κB Pathways: In Vivo and Vitro Studies

In conclusion, these results suggest that paeonol may be a potential therapeutic agent in the treatment of OA.

Source: Inflammation - September 6, 2017 Category: Allergy & Immunology Source Type: research